Stoyan Bojinov: RBS, the well-known financial institution and relative newcomer to the ETF space. introduced its sixth ETN this week. This new ETN, the NASDAQ-100 Trendpilot ETN (NYSEARCA:TNDQ), will join the issuer’s family of “Trendpilot” ETPs, which offer exposure to a dynamic trading Read more…

NYSE:DRGS, NYSE:TNDQ, NYSE:TWTI, TBAR, TRND, TRNM

In trading on Thursday, the iShares MSCI ACWI ex US Materials Index (NYSEArca:AXMT) is outperforming other ETFs, up about 7.87% on the day. Also up on the day are the Read more…

NYSE:AXMT, NYSE:DRGS, NYSE:EMSA, NYSE:GRN, NYSE:HGEM, NYSE:VXDD

Michael Johnston: RBS rolled out its fifth ETN this week, debuting a product that offers exposure to the world’s largest pharmaceutical firms. The new Global Big Pharma ETN (NYSE:DRGS) will seek to replicate Read more…

IHE, NYSE:DRGS, NYSE:PPH, PJP, XPH

RBS Securities Inc. (RBSSI) today announced the launch of the fifth exchange traded product in its growing suite of Exchange Traded Notes (ETNs). The RBS Global Big Pharma Exchange Traded Notes will be issued by The Royal Bank of Scotland plc (RBS plc) and will be listed on Read more…

FUND LAUNCH, NYSE:DRGS